Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus

American Journal of Tropical Medicine and Hygiene

Volumn 75, Issue 4, 2006, Pages 702-709

  Kolokoltsov, Andrey A ^a   Wang, Eryu ^a   Colpitts, Tonya M ^a   Weaver, Scott C ^a   Davey, Robert A ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; DIAGNOSTIC AGENT; EPITOPE; LUCIFERASE; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS FUSION PROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANTIBODY TITER; ARTICLE; ASSAY; CELL STRAIN HEK293; CONTROLLED STUDY; ENCEPHALITIS; ENCEPHALITIS VIRUS; ENCEPHALOMYELITIS; GENE EXPRESSION; HORSE; HUMAN; HUMAN CELL; NONHUMAN; SCREENING; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; CELL LINE; CLASSIFICATION; CROSS REACTION; GENETICS; HAMSTER; HORSE DISEASE; IMMUNOLOGY; MURINE LEUKEMIA VIRUS; REGRESSION ANALYSIS; REPORTER GENE; SERODIAGNOSIS; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VESICULAR STOMATITIS VIRUS; VIROLOGY;

EQUIDAE; VENEZUELAN EQUINE ENCEPHALITIS VIRUS;

ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES, VIRAL; CELL LINE; CRICETINAE; CROSS REACTIONS; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; ENCEPHALOMYELITIS, VENEZUELAN EQUINE; EPITOPES; GENES, REPORTER; HORSE DISEASES; HORSES; HUMANS; LEUKEMIA VIRUS, MURINE; LUCIFERASES; NEUTRALIZATION TESTS; REGRESSION ANALYSIS; VESICULAR STOMATITIS-INDIANA VIRUS; VIRAL ENVELOPE PROTEINS; VIRAL FUSION PROTEINS; VIRAL VACCINES;

EID: 33750610530     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2006.75.702     Document Type: Article

References (25)

1. Johnson KM, Martin DH, 1974. Venezuelan equine encephalitis. Adv Vet Sci Comp Med 18: 79-116.
2. Fact sheet: Arboviral Encephalitis: CDC.
3. Canonico PG, Kende M, Luscri BJ, Huggins JW, 1984. In-vivo activity of antivirals against exotic RNA viral infections. J Antimicrob Chemother 14 (Suppl A): 27-41.
4. Kinney RM, Chang GJ, Tsuchiya KR, Sneider JM, Roehrig JT, Woodward TM, Trent DW, 1993. Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5′-noncoding region and the E2 envelope glycoprotein. J Virol 67: 1269-1277.
5. Roehrig JT, Mathews JH, 1985. The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes. Virology 142: 347-356.
6. Kolokoltsov AA, Weaver SC, Davey RA, 2005. Efficient functional pseudotyping of oncoretroviral and lentiviral vectors by Venezuelan equine encephalitis virus envelope proteins. J Virol 79: 756-763.
7. Kolokoltsov AA, Davey RA, 2004. Rapid and sensitive detection of retrovirus entry by using a novel luciferase-based content-mixing assay. J Virol 78: 5124-5132.
8. Berge TO, Banks IS, Tigertt WD, 1961. Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea pig heart cells. Am J Hyg 73: 209-218.
9. Weaver SC, Salas R, Rico-Hesse R, Ludwig GV, Oberste MS, Boshell J, Tesh RB, 1996. Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group. Lancet 348: 436-440.
10. Wang E, Paessler S, Aguilar PV, Smith DR, Coffey LL, Kang W, Pfeffer M, Olson J, Blair PJ, Guevara C, Estrada-Franco J, Weaver SC, 2005. A novel, rapid assay for detection and differentiation of serotype-specific antibodies to Venezuelan equine encephalitis complex alphaviruses. Am J Trop Med Hyg 72: 805-810.
11. Chen C, Okayama H, 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7: 2745-2752.
12. Kolokoltsov AA, Fleming EH, Davey RA, 2005. Venezuelan equine encephalitis virus entry mechanism requires late endosome formation and resists cell membrane cholesterol depletion. Virology.
13. Beaty BJ, Calisher CH, Shope RE, 1989. Arboviruses. Schmidt NJ, Emmons RW, eds. Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections. Washington DC: American Public Health Association, 797-855.
14. National Institutes of Health, 2002. Guidelines for Research Involving Recombinant DNA Molecules: NIH.
15. Kinney RM, Trent DW, 1982. Conservation of tryptic peptides in the structural proteins of viruses in the Venezuelan equine encephalitis complex. Virology 121: 345-362.
16. Roehrig JT, Day JW, Kinney RM, 1982. Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodies. Virology 118: 269-278.
17. Hunt AR, Johnson AJ, Roehrig JT, 1990. Synthetic peptides of Venezuelan equine encephalomyelitis virus E2 glycoprotein. I. Immunogenic analysis and identification of a protective peptide. Virology 179: 701-711.
18. Sandrin V, Muriaux D, Darlix JL, Cosset FL, 2004. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses. J Virol 78: 7153-7164.
19. Zavada J, 1982. The pseudotypic paradox. J Gen Virol 63: 15-24.
20. Sanders DA, 2002. No false start for novel pseudotyped vectors. Curr Opin Biotechnol 13: 431-442.
21. Bartosch B, Bukh J, Meunier JC, Granier C, Engle RE, Blackwelder WC, Emerson SU, Cosset FL, Purcell RH, 2003. In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc Natl Acad Sci USA 100: 14199-14204.
22. Han DP, Kim HG, Kim YB, Poon LL, Cho MW, 2004. Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein. Virology 326: 140-149.
23. Rother RP, Fodor WL, Springhorn JP, Birks CW, Setter E, Sandrin MS, Squinto SP, Rollins SA, 1995. A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody. J Exp Med 182: 1345-1355.
24. Young NA, Johnson KM, 1969. Antigenic variants of Venezuelan equine encephalitis virus: their geographic distribution and epidemiologic significance. Am J Epidemiol 89: 286-307.
25. Weaver SC, Ferro C, Barrera R, Boshell J, Navarro JC, 2004. Venezuelan equine encephalitis. Annu Rev Entomol 49: 141-174.